Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Fibrogen Inc CS (FGEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 4,347,299
  • Shares Outstanding, K 78,970
  • Annual Sales, $ 179,580 K
  • Annual Income, $ -61,680 K
  • 36-Month Beta 1.74
  • Price/Sales 24.32
  • Price/Cash Flow 0.00
  • Price/Book 15.51

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.40 +9.23%
on 09/26/17
60.15 -8.48%
on 10/04/17
+2.30 (+4.36%)
since 09/18/17
3-Month
33.05 +66.57%
on 08/01/17
60.15 -8.48%
on 10/04/17
+20.40 (+58.87%)
since 07/18/17
52-Week
15.60 +252.88%
on 11/03/16
60.15 -8.48%
on 10/04/17
+37.10 (+206.69%)
since 10/18/16

Most Recent Stories

More News
FibroGen Announces Acceptance by China FDA of Roxadustat New Drug Application (NDA) for Treatment of Anemia Associated With Dialysis and Non-Dialysis Chronic Kidney Disease (CKD)

FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, and its subsidiary FibroGen China Medical Technology Development Co., Ltd. (FibroGen China), today announced that the China Food...

FGEN : 55.05 (-0.45%)
FibroGen Appoints Gerald Lema to Board of Directors

FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, today announced that Gerald Lema, former President of Asia Pacific at Baxter International, has been appointed to the Company's...

BAX : 63.84 (-0.13%)
FGEN : 55.05 (-0.45%)
Fibrogen Presents Latest Data From Phase 2b Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis at European Respiratory Society (ERS) International Congress 2017

FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, announced today positive results from the company's Phase 2b randomized, double-blind, placebo-controlled study (Study 067) in patients...

FGEN : 55.05 (-0.45%)
FibroGen Announces Pamrevlumab Oral and Poster Presentations at European Respiratory Society International Congress 2017

FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, today announced oral and poster presentations on pamrevlumab, an anti-CTGF monoclonal antibody in late-stage development for the...

FGEN : 55.05 (-0.45%)
Fibrogen Inc Has Returned 83.2% Since SmarTrend Recommendation (FGEN)

SmarTrend identified an Uptrend for Fibrogen Inc (NASDAQ:FGEN) on February 17th, 2017 at $24.34. In approximately 6 months, Fibrogen Inc has returned 83.17% as of today's recent price of $44.58.

FGEN : 55.05 (-0.45%)
Fibrogen Inc Rises 2.64% on Heavy Volume: Watch For Potential Pullback

Fibrogen Inc (NASDAQ:FGEN) traded in a range yesterday that spanned from a low of $42.55 to a high of $44.85. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $43.70...

FGEN : 55.05 (-0.45%)
After Yesterday's Rally of 1.94% Shares Could Potentially Pullback

Fibrogen Inc (NASDAQ:FGEN) traded in a range yesterday that spanned from a low of $41.15 to a high of $42.65. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $41.70...

FGEN : 55.05 (-0.45%)
Fibrogen Inc Has Returned 69.5% Since SmarTrend Recommendation (FGEN)

SmarTrend identified an Uptrend for Fibrogen Inc (NASDAQ:FGEN) on February 17th, 2017 at $24.34. In approximately 6 months, Fibrogen Inc has returned 69.47% as of today's recent price of $41.25.

FGEN : 55.05 (-0.45%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Sangamo Therapeu (SGMO, INSM, NVTA, FGEN, CYTK)

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

SGMO : 14.15 (-2.41%)
NVTA : 9.89 (+0.41%)
CYTK : 15.35 (-0.97%)
FGEN : 55.05 (-0.45%)
INSM : 27.82 (-0.68%)
FibroGen, Inc. Announces Proposed Follow-On Offering of Common Stock

FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, today announced that it intends to offer and sell up to $300 million of its common stock in an underwritten follow-on offering....

FGEN : 55.05 (-0.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

FibroGen, Inc. is a research-based biotechnology company. It is focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. The Company develops Roxadustat that is in Phase III clinical development...

See More

Support & Resistance

2nd Resistance Point 57.05
1st Resistance Point 56.05
Last Price 55.05
1st Support Level 54.50
2nd Support Level 53.95

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart